Answer
Enalapril is converted to enalaprilat, which inhibits angiotensin-converting enzyme, reducing formation of the pressor substance angiotensin II and aldosterone secretion; blood-pressure lowering is believed to result primarily from suppression of the renin–angiotensin–aldosterone system.
Sources for this answer
- Innovace TabletsOrganon Pharma (UK) Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 37Document updated
Sources checked